Denosumab No Better than Bisphosphonates for Preventing Fracture, and the Cost Is Much ...
Sep 15, 2020 - This meta-analysis found no evidence that the monoclonal antibody denosumab reduces the risk of fracture more than bisphosphonates.
American Family Physician : POEMs
https://www.aafp.org/afp/2020/0915/p375a.html
navigate_before 1 navigate_next